|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.24 USD | +1.64% |
|
-1.79% | +21.09% |
| 07-20 | NeoGenomics Settles DOJ Investigation Related to Laboratory Collaboration Program | MT |
| 07-09 | NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic For Prostate Cancer | CI |
| Market Cap | 1.85B 1.63B 1.51B 1.39B 2.61B 179B 2.66B 18.08B 7.05B 87.74B 6.96B 6.81B 304B | P/E 2026 * |
-31.9x | P/E 2027 * | -49.6x |
|---|---|---|---|---|---|
| Enterprise Value | 1.85B 1.63B 1.51B 1.39B 2.61B 179B 2.66B 18.08B 7.05B 87.74B 6.96B 6.81B 304B | EV / Sales 2026 * |
2.32x | EV / Sales 2027 * | 2.11x |
| Free-Float |
97.95% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: NeoGenomics, Inc.
| 1 day | +1.64% | ||
| 1 week | -1.79% | ||
| Current month | -2.40% | ||
| 1 month | +27.14% | ||
| 3 months | +74.08% | ||
| 6 months | +9.79% | ||
| Current year | +21.09% |
| 1 week | 13.66 |  | 15.04 |
| 1 month | 11.63 | | 15.57 |
| Current year | 7.06 | | 15.57 |
| 1 year | 4.72 | | 15.57 |
| 3 years | 4.72 | | 21.22 |
| 5 years | 4.72 | | 54.74 |
| 10 years | 4.72 | | 61.57 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anthony Zook
CEO | Chief Executive Officer | 65 | 2025-03-31 |
Abhishek Jain
DFI | Director of Finance/CFO | 57 | 2026-03-01 |
Warren Stone
PSD | President | 53 | 2025-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Lynn Tetrault
CHM | Chairman | 64 | 2021-10-06 |
Stephen Kanovsky
BRD | Director/Board Member | 63 | 2017-07-18 |
Michael Kelly
BRD | Director/Board Member | 69 | 2020-07-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/23/26 | Free | Director | 23,909 | 0.0184% | ||
| 6/15/26 | Sell | Chairman | -5,307 | 0.0041% | ||
| 6/9/26 | Sell | Chairman | -5,307 | 0.0041% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.64% | -1.79% | +121.81% | -18.35% | 1.82B | |
| +0.18% | -4.57% | +89.17% | +436.79% | 37.84B | |
| +3.40% | +7.00% | +15.45% | +32.76% | 23.08B | |
| 0.00% | -3.17% | -24.50% | -41.14% | 7.19B | |
| +2.97% | -0.70% | +6.72% | +74.28% | 4.66B | |
| -0.70% | -2.10% | +12.32% | +47.54% | 2.94B | |
| +1.25% | -4.17% | -21.66% | +703.30% | 1.86B | |
| -2.18% | -5.42% | -8.99% | -62.78% | 1.85B | |
| +7.66% | +0.97% | +14.27% | +5.81% | 1.79B | |
| -4.01% | -19.58% | +6.04% | -30.48% | 1.55B | |
| Average | +1.02% | -2.63% | +21.06% | +114.77% | 8.46B | |
| Weighted average by Cap. | +1.25% | -2.02% | +45.19% | +219.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 800M 703M 654M 601M 1.13B 77.29B 1.15B 7.81B 3.04B 37.88B 3B 2.94B 131B | 881M 774M 719M 661M 1.24B 85.04B 1.26B 8.59B 3.35B 41.67B 3.3B 3.23B 144B |
| Net income | -57.81M -50.81M -47.22M -43.42M -81.4M -5.58B -82.96M -564M -220M -2.74B -217M -212M -9.47B | -37.05M -32.56M -30.26M -27.83M -52.16M -3.58B -53.16M -361M -141M -1.75B -139M -136M -6.07B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-23 | US$14.24 | +1.64% | 1,901,114 |
| 26-07-22 | US$14.01 | -3.04% | 1,708,800 |
| 26-07-21 | US$14.45 | +1.47% | 1,577,868 |
| 26-07-20 | US$14.24 | -2.53% | 2,092,728 |
| 26-07-17 | US$14.61 | -1.55% | 10,766,528 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NEO Stock
Select your edition
All financial news and data tailored to specific country editions
